The Ultimate Directory on Healthcare Webinars

Join this webinar series to discover how AI enhances diagnostic accuracy and provides prognostic insights and treatment assessment as well as understand the balance between AI-driven innovation and safeguarding patient privacy and data integrity in oncology clinical trials. Participants will learn how electronic clinical outcome assessment (eCOA) equivalence studies have paved the way for accessibility functionality testing for oncology trials, discover accessibility features for scientific assessment on the potential impact on data integrity and hear about future endeavors to make accessibility a reality for trial participants. The series will help viewers understand the unique aspects of assessing cardiac safety within an oncology development program, improve awareness of electrocardiogram (ECG) best practices, comprehend the importance of objective safety measurements with patient-reported outcomes and learn to enable early detection using wearable sensor technology to proactively monitor patients.

The new framework of globally applicable standards for clinical trial data, effective from September 9, 2023. All companies now need to implement the EMA guideline on computerised systems and electronic data in clinical trials if the data will be used to support a marketing authorization in the European Union (EU). Effective on September 9, 2023, the guideline sets forth consolidated requirements on the use of computerized systems, the collection and use of electronic data and introduces a new framework of standards to be upheld by sponsors, investigators and their service providers globally. The new guideline impacts sponsors, investigators and service providers involved in running clinical trials. Join this ICON webinar to gain the knowledge required to achieve compliance with the new regulatory regime, with a strong focus on data accuracy, security and operational efficiency of the trial.

Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies. Explore the promising efficacy of psychedelics like psilocybin, MDMA, 5-methoxy-dimethyltryptamine, and ibogaine in treating conditions such as depression, PTSD, anxiety, and substance use disorder. During this webinar, we will examine the diverse mechanisms of action underlying these psychedelic compounds, discuss the important results observed in clinical trials, highlight the pivotal role of organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) in shaping the regulatory landscape for psychedelic medicines, explore the pipeline of next-generation psychedelic medicines, and gain insights into the recent guidance issued by the US FDA and explore the regulatory pathways for the clinical study and approval of psychedelics in both Australia and the United States.

This webinar is for users with a Zoom account. New to Zoom? Sign up free. Dr. Rodney French: Dr. French is a graduate of UBC Faculty of Medicine (1996) and completed his residency in Plastic Surgery at Dalhousie University (2002). He completed a Masters degree in Surgical Education at Mount Saint Vincent University and Dalhousie University (2003). He completed a one year fellowship in Hand, Wrist and Microsurgery at Harvard University (2004). He has a Diploma in Sports Medicine (2017) from the Canadian Association of Sport and Exercise Medicine (CASEM). In 2021 he completed a Masters Certificate at Harvard in Medicine And The Media. Jean-François Ouellet Jean-François graduated from McGill University with a B Sc. (O.T.) in 2003 and holds a current registration to practice in the province of Quebec as an Occupational Therapist (OEQ member). He has been working in private practices since 2003 exclusively treating elbow, wrist and hand injuries. He has been a Certified Hand Therapist since 2009. He was coordinator of the Montreal Hand Interest Group for 8 years. He worked as an assistant-teacher for orthotic labs at McGill University from 2009 to 2014. He has been an invited speaker at numerous Quebec Hand Surgery Conferences (ASCPEQ) as well as for the Canadian Society of Hand Therapists (CSHT). Jean-François has been mentoring other therapists and has a passion for sharing his knowledge. He regularly teaches wrist and hand examination courses to GPs through GMFs. He also works with professional athletes from various fields and associations (NHL, MLS, UFC, CFL, olympians, performing artists, QMJLH,...). He has joined Kinatex Brossard in 2023. He serves as President for the Canadian Society of Hand Therapist.

The All-Ireland Chromatin Consortium was established in 2021 to foster collaborations between researchers located across the whole of Ireland, promote scientific exchange, and to facilitate networking between students, postdocs, and PIs working in the field of chromatin biology. Keynote Speaker - Robin Allshire, Ph.D. - Professor of Chromosome Biology, Wellcome Trust Centre for Cell Biology, University of Edinburgh > Seminar Title: ‘Epigenetic Routes to Antifungal/Fungicide Resistance’ Prof. Robin Allshire is Professor of Chromosome Biology at University of Edinburgh and a Wellcome Trust Principal Research Fellow. His research group at the Wellcome Trust Centre for Cell Biology focuses on the epigenetic mechanisms governing the assembly of specialised domains of chromatin and their transmission through cell division. He is elected an EMBO member and Fellow of the Royal Society and Academy of Medical Sciences.

“How Legendary Changemakers Avoid Burnout? And What You Can Do to Preserve your Energy and Create your Aspired Social Impact” Another world is not only possible, she is on her way. On a quiet day, I can hear her breathing. In today's volatile world, we're witnessing historic levels of anxiety as a result of war in three continents: Europe, Africa, and the Middle East, climate catastrophes, and an unprecedented level of humanitarian crisis. Jennifer Brown writes her in article, “How Advocates for Inclusion Keep from Burning Out,” that as empathetic allies, advocates for inclusion are particularly susceptible to increased levels of anxiety as they experience the pressure to outperform themselves while representing marginalized identities and take in other people’s experiences. Advocates need to strategize their advocacy energy to prevent burnout and a systematic process to overcome burnout once identified. In this webinar, the Artist Changemaker, Shumaila Hemani, Ph.D. will offer three essential strategies to overcome burnout based on her upcoming online course: Resurgence: The Deep Listening Path to Recovering from Advocacy Burnout. Combining deep listening practices with mindfulness meditation practice and wellness, Hemani will propose we shift our approach from considering burnout as an individual-centric issue to addressing it as a systemic issue that is a by-product of the hustle culture and needs systems thinking to build resources and support within our social ecology. The participants will receive free resources, including an ebook and audio meditation to support their recovery. This webinar is relevant for any advocate who has experienced burnout during their advocacy journey.

EFAD's ESDN Diabetes - "Type 1 Diabetes and Celiac Disease in Pediatrics"

Join us for a webinar on barriers to patient partnership and equity in health research.

This webinar will discuss the importance of surveillance as an infection prevention and control practice in neonatal care. The webinar will be an opportunity to present the newly-developed NeoIPC surveillance toolkit, and to hear from experts with longstanding experience in surveillance and hospital-acquired infections. Speakers include: Aikaterini Mougkou, Expert in Antimicrobial Resistance and Healthcare-Associated Infections, European Centre for Disease Prevention and Control (ECDC) Begoña Loureiro, Cruces University Hospital; IIS Biocruces Bizkaia, Bilbao, Spain Brar Piening, Senior Physician, Institute of Hygiene and Environmental Medicine, Charité – Universitätsmedizin Berlin, Germany Christina Obiero, Researcher, KEMRI – Wellcome Trust Research Programme, Kilifi, Kenya.

To successfully treat tuberculosis it is an absolute necessity that the antimicrobial agents used reaches the site of infection in sufficient amounts. This webinar will discuss the link between drug doses and treatment outcome, the main pharmacokinetic processes, site-of-disease pharmacokinetics in pulmonary TB, combination treatment and drug-drug interactions, and the population approach using mathematical models. The target audience includes healthcare professionals, decision makers, policy makers, researchers, and the TB community.